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The pX sequcncc of human T cell Icukcmia virus type I (HTLV-I) has been thought to bc cxprcsscd as a doubly spliced mRNA thal codes for 
p40lax. p27rcx and p21X. However. WC identified a novel allcrnativcly spliced mRNA in the HTLV-I infccvd cells by using rcvcrsc transcription 
rollowed by the polymcrasc chain rcaction. This mRNA conlains only the firs1 and third cxons of the doubly spliced mRNA and encodes only 
p2lX. Our data thaw this mRNA is rcsponsiblc for expressing p2lX exists in most or HTLV-I infcclcd cells strongly suggcs~s that p2lX may play 
a crucial role for HTLV .I rcplicalion. 
Human T cell leukemia virus I (HTLV-I); RNA splicing; PX gene; Gene product, rcx; Polymcrasc chain reaction 
I, INTRODUCTION 
The human T cell leukemia virus type I (HTLV-I) is 
a human retrovirus that has been shown to be a causa- 
tive agent of a human malignant disorder, adult T cell 
leukemia (ATL) [l-3], and associated with a subgroup 
ofchronic progressive myelopathies, tropical spastic pa- 
raparesis/HTLV-l-associated myelopathy (TSP/HAM) 
[4,5]. It has a unique regulatory sequence termed pX in 
addition to the grog, pal and WV sequences present in all 
replication-competent retroviruses [6]. This region is ex- 
pressed as a 2.1 kb doubly spliced mRNA [7], and the 
mRNA (tuslres mRNA) has two overlapping open 
reading frames, designated IUS and res [8]. IUS encodes 
p40tax, which was shown to be a trans-activator of the 
long terminal repeat (LTR) of HTLV-I [g-13] and 
several cellular genes [14-l 71. rex encodes p27rex and 
p21X [l8], and p27rex is a post-transcriptional regu- 
lator, which induces the accumulation of unspliced viral 
gr/g-pal mRNA [19,20]. The complete amino acid sc- 
quence of p21X is contained within the C-terminal por- 
tion of p27rex [6], but the function of p21X is still not 
known [8,21]. 
protection assay [21]. Furthermore, from other data, 
rasl~s mRNA had been concluded to also code for 
p21X as well as p27rex as described elsewhere [I 81. 
Although a possibility had been implied to be that 
p27rex and p2lX might be independent translation 
products from differently spliced mRNA [8], no 
evidence for alternatively spliced mRNA other than ras/ 
rex mRNA was found by blotting or by a nuclease Sl 
Recently, to detect mRNA that is expressed in small 
amounts, a highly sensitive method involving po- 
lymerase chain reaction coupled to reverse transcription 
(RT-PCR) was developed [21,22]. Until quite recently, 
no expression of HTLV-I was detected by immunofluo- 
rescence analysis or RNA blot analysis in most fresh 
peripheral blood mononuclear cells (PBMC) of patients 
with ATL [23-261. However, applying RT-PCR, recent 
reports indicated that the expression of ~uslres mRlaA 
could be detected in their fresh PBMC [27,28]. Also, in 
another report, RT-PCR has been applied to analysis 
for a complex series of splicing events of viral mRNA 
transcripts in human immunodeficiency virus type 1 
(HIV-I) infected cells [29]. HIV contains seven addi- 
tional genes (w, rev, IL’I’, vpu, vpr. rifand tzj) in addi- 
tion to the signatory retroviral genes gug, pal and ew 
[30]. The report has showed that the two-exon ncJspc- 
chic transcript represented the final product of the com- 
plex series of splicing pat.hways of HIV-1 infected cells 
[29], although after this discovery, it is still documented 
that the conventional double spliced mRNA is only 
responsible to code for rtcf [30,31]. 
Cotw.~potdcmv uddrcss: H. Igdrashi, Shionogi lnstitulc for Medical 
Science, 2-5-l Mishima, SCEU-shi, Osaka 566, Japan. Fax: (RI) (6) 382 
2598. 
In this report, the possibility that p27rex and p21X 
are independent ranslation products from differently 
spliced mRNA other than ros/t~x mRNA was cxam- 
incd by RT-PCR or by a highly scnsitivc detection pro- 
cedure of modified RT-PCR coupled to a double PCR 
with nested primers. WC focused on analyzing the ex- 
pression-mechanisms of p2lX to understand its ftinc- 
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tion. Thereby we first found a novel mRNA that alter- 
natively spliced the second cxon from rtrslws mRNA 
and was composed of the first and third exon. like the 
trcL/‘specific mRNA in HIV as described [29]. Second, 
this new two-exon mRNA was demonstrated to specifi- 
cally code for p2lX, so it is named p2lX mRNA, signi- 
fying the p2lX specific mRNA. In addition to these, 
other similar alternatively spliced mRNA in addition to 
p2lX mRNA detected by highly sensitive RT/TS-PCR 
in HTLV-I infected cells were described. 
2. MATERIALS AND METHODS 
Human T-cull lines carrying HTLV-I (MT-I. MT-2. MT-4. TL-Su. 
and H582) and ao(-carrying HTLV-I (Mob-4) wcrc cultured in a 
medium. RPMI-1640 supplcmenrcd with 10% heat-inactivated licml 
bovine strum (FBS). The MT-i [33] and H582 (a gifr from H. Ssto. 
Kyushu Univcrsiry) (Hayai in [8]) cell lines wcrc dcrivcd from 
Icukcmia cells ofihc PBMC from palicnts with ATL. The MT-2 and 
hlT-4 cell lines wcrc csurblishcd by cocultivation of human cord blood 
lymphocyrcs of normal subjcc(s with the PBMC of ATL p;uicnrs 
[33.34]. The TL-SII cell lint was csrablishcd from the PBMC of an 
asymp(orna(ic HTLV-I carrier [ZG]. The X1011-4 cell lint W~IS csrab- 
lishcd from PBhlC of a patienl with aculc lymphoblas(ic Icukcmia 
(ATCC CRL-I 582). 
2.2. Sbvrrlrcric Uli~r~li~r~ll~Ulil/I:v cd u/h tWrgoll,S 
OliBonuclcotidc primers for PCR and probes for Sou(hcrn hy 
bridization analysis wcrc synthesized on a Cyclone DNA symhcsizcr 
(Bioscarch Inc.. CA, USA) by me phosphoramidiic mcihod and 
purillcd wi(h oligonuclcoridc purificalion cdrlridgcs (Applied Bio- 
sys(cms Inc.. CA, USA). A random hcxadcoxynucleoiidc primer. 
avian mycloblas(osis virus revcrsc rranscripiasc, rcs(riciion cn- 
donuclcascs. TJ polynuclco(idc kinasc. T4 DNA ligasc. and T/~o/tr~r:; 
rrqrrrrrffic~rs DNA polymerase (Taq poiymcrasc) wcrc purchased from 
Takara Shuzoh (Kyoto. Japan). [&‘P]dCTP and [y-“‘P]ATP wcrc 
from Amcrsham (EnBland). 
2.3. RNA prcprrrrrriurr m rl Nortlwrr~ utrtr!l:sis 
RNA from cell lines was isolated by the guanidinium-acid-phenol 
mcihod as dcscribcd previously [35]. The amoum and quality of RNA 
wcrc cs(ima(cd by measuring the /I:,,, and AZh,, and by analyzing a 
sample on a formilldcllydc-;lgarosc pl and comparing (hc rclativc 
inrcnsirics of the b:mds of I8 S and 28 S rRNAs visualized by siaining 
with crhidium bronridc. 
I5 fig lolaI RNA was fractionmcd by formaldchydc-agrosc Bcl 
clcctrophoresis ml lrdnsfcrrcd 10 a nylon mcmbranc lillcr (Hvbond- 
N+: Amcrsham). The hhcr was prchybridizcd in a prchybrid*iza(ion 
buffer (6x SSC, 0.5% SDS. 5x Dcnhardt’s, 100 ~&ml calf (hymus 
DNA) RI 37°C for 2 h and hybridized for I6 h ;II 37’C in ~hc prchy- 
bridizarion buffer including a oligonuclcotidc probe (oligo-probe) (I- 
1.5~10’ cpm) labclcd with [y-“P]ATP by using T4 polynuclcotidc 
kinasc or a~ 6W in (hc prchybridizntion buffer including a double 
strand DNA fragmcm probe (dsDNA fragmcm-probe) (I-2x IO’ cpm) 
Iabclcd whh [a-?P]dCTP by polymcrasc chain reaction whh Taq 
DNA polymcrusc. Then the fltcr hybridized wirh an oligo-probe wirs 
washed in lx SSC and 0.5% SDS for I5 min al 37’C. followed by 30 
min washes al 55°C in 3 M ~c~ramcthylan)monium chloride and 0.5% 
SDS solubon, andcxposcd to Kodak XAR film with a single inrcnsify- 
ing SC~CW iIt -WC for 7 days. Thcsc condhions did no( allow hy- 
bridization of scqucnccs carrying a single misalutch [3G]. The o(!lcr 
liltcr hybridized with a dsDNA fragmcnl-probe was washed in Ix SSC 
and 0.5% SDS for IO min a( 65°C. followed by 15 min washes a~ 65OC 
in 0.1~ SSC and 0.5% SDS, and cxposcd to Kodak XAR Blm wiih a 
sin& inlcnsifyirrg screen at -80°C for 2 days. 
I28 
PCR) 
RT-PCR \vas carried OUI as dcscribcd [23] wi(h minor modilica- 
(ions. Briefly. 0.25 fig of rolal RNA was anncalcd with 500 ng of a 
rirrrdonr hesadcoxynuclco(idc primer and was rcvcrsc (ranscribcd with 
I5 units ofavian mycloblastosis virus rcvcr-sc (ranscrip(ase al 42’C for 
I II. Then X.3 /II of 6x PCR buffer (lx PCR buffcr consists of 16.6 niM 
anrmonium sulfa~c. 67 mM Tris-HCI (pH 8.8 aI 25°C). 6.7 mM mrrg- 
ncsium chloride. IO mhl 2- mcrcaproc(hanol. 7.7 flM EDTA, and 
bovine serum albumin at 170 pg/ml). 5 ~1 each of I5 mM dATP. I5 
nrX1 dCTP. I5 11lM dGTP. and I5 mM TTP. and 50 pmol ofcach PCR 
primer wcrc uddcd (o the rcac(ion vcsscl in a final volume of 50,ol. 
The scqucnccs of (hc primers for PCR (PXI. PX2, PX3. PX4 and 
PXIO) and of probes for Southern hybridizauon :malysis (PXS and 
PX6) arc sho\vn in Fig. I. PXI irnd PX2 arc locarcd upsrrcam and 
downsrrcam. rcspcclivcly. of the puta(ivc splice junc(ion si(c of p2lX 
IuRNA. The amplilicd DNA fragmcnis oblaincd \ri(h PXI and PXS 
;riLcr PCR wcrc cspcc~cd LO bc SOB-base pairs (bp) for rcrs1re.v mRNA 
atld 317.bp for p2lX mRNA. The probe PX6 is ir 20.mcr of (r.2 
scqucnccsurrounding(hc pu~a~ivcspliccjunc(ion sitcofp2lX mRNA. 
PX3 and PX4 arc identical IO RP:i3 and RPX4. rcspeclivcly. as dc- 
scribed [27]. PX3 and PX4 arc localcd upsrrcam and downstream. 
rcspcctivcly, of rhc second splice junction si(c of roshc~ mRNA. The 
o!aplifrcd DNA fragmcnrs obraincd wirh PX3 and PX4 af(cr PCR 
wcrc I44-bp for /rrsiws mRNA. The probe PX5 idcmical 10 RPXPRI 
as described previously [27] is a 20-mcr of the scqucncc surrounding 
1111: second splice junction she of ~a.vl~.u mRKA. Then PCR was 
crirricd out in a DNA Thermal Cyclcr (Pcrkin-ElmcdCcms. CT. USA) 
for 35 cycles whh 2.5 uni(scfTaq polymcrasc. The reaction conditions 
wcrc I min ar 94°C for dcnatura(ion. I min aI WC for primer 
armcaling. and 2 min a( 72°C for primer cxlcnsion. Afmr lhc reaction. 
one-fifth of (hc ampli6cd DNA produc( was clcc(rophorcscd in a 
composirc gel 0f2% Nusicvc agarosc and I % sumderd agaroso (FMC 
BioProducls. ME. USA) and smincd wi(h cmidium bromide (0.5,+/ 
1111). The prcscncc of a band with ihccxpcclcd size for each primer pair 
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Fig. I. Trdnscriplion map of HTLV-I whh locatiori and scqucnccs of 
oligonuclco(idc primers and probes for RT-PCR ;u);rlysis. (A) Gwom- 
iu s(ruc(urc of HTLV-I provirus and (hrcc (ypical RNA (ranscripls 
irrtd u novel PSI X-spccilic rranacrip(. Sd. splice donor site; sa, splice 
rrcccplor she. The p401ax. p27rcx und p2lX ini(ia(ion codons (AUG) 
irrc indicalcd by the vcr(ical arrowheads. The loc;uions and oricnm- 
lion of (hc primers for PCR, PXI. PX2, PX3. PX4 and PXIO, urc 
SIIOWI) by the horizomal arrows. (B) Sequences ofprimers and probes 
used in PCR and Soulhcrn blot analysis. DNA scqucncc informrrlion 
from Sciki CI al. [G] is used. PXS and PXG arc idcn(ic;rl to (hc scqucnccs 
surrounding (hc splice juncrion shcs of the rrrslrrs and the p?l X- 
specific (runscripls, rcspcclivcly. The colons in thcsc probe-scqucnccs 
indiciuc lhc splice junclioa shcs. 
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was dclcrmincd lo bc positive. To confirm lhc spccificily by hybridiza- 
lion. the gel was dcnalurcd in alkaline solution and lrdllsl’crrcd to a 
nylon mcmbranc lillcr (Hybond-N+). Aficr fixation of UV irradia- 
lion. ~hc liltcr WIS hybridized al 42°C wi\h a J2P-cnd-labclcd oligo- 
probe (I-1.5x10’ cpm) for 16 h. Prchpbridizalion and hybridiza&m 
wcrc carried out as dcscribcd [37]. Then rhc liltcr was wshcd in 5x 
SSPE al 48°C and cxposcd IO Kodak XAR lilm with a single intcnsify- 
ing screen for 1 h at -80°C. 
To dctcrminc easily and specifically Ihc prcscncc of 111~ HTLV-I 
proviral scqucnccs, WC have dcvclopud the two-step-?CR (TS-PCR) 
mchod as dcscribcd previously [38]. which is a modified ncstcd double 
PCR method [39] used with an optimal conccmration orprimcr pairs 
in the lirst amplification step. So. to dclcct mRNA, a very highly 
scnsilivc mc~hod involving the TS-PCR coupled to rcvcr~c transcrip- 
tion (RT/TS-PCR) was dcvc!opcd. Briclly, alicr the RT reaction as 
mcntioncd abovc. the lirsl slcp PCR was pcrformcd for 25 cycles 
under the same reaction conditions as mcmioncd abort cxccpt for 
using one picomolc of each primer (PX I and PXZ). One-lcnth or the 
first step PCR DNA producl was used as tcmplatc DNA for the 
second swp PCR with 100 pmol ol each primer (PXIO rnd PX4 for 
targeting p2lX mRNA. and PX3 and FX4 Tar raslrcs niRNA) ror 35 
cycles. The other rcaclion condilions were lhc same as those mcn- 
lioncd above. Ancr the reaction. ~hc amplincd DNA product was 
dclcrmincd by slaining with clhidium bromide and Southern hy- 
bridization. The lina! amplilicd DNA I‘ragmcms alicr RT/TS-PCR 
wcrc cxpccicd 10 bc 272-bp for r(t.rlre.~ mRNA and 81.bp for p2lX 
mRNA when amplified with primers PXIO and PX4 alid 144.bp for 
rtrslrcs mRNA when amplified with primers PX3 and PX4. 
In some cspcrimcnts. g&purified PCR products wcrc scqucnccd 
directly by a modification of\hc didcoxy chain tcrminalion procedure 
[40] with a Scqucnasc kh (Unilcd Slates Biochemical. OH. USA). 
When subcloning bcforc scqucncing \W rcquircd. the 317-bp Frag- 
mcm amplified from p2lX mRNA in H582 by RT-PCR willi primers 
PXI ;md PX2 was SCpdrillCd rrom unincorporalcd prilncrs nnd the 
SOI-bp fragmcnl dcrivcd rrom ~trslrcs mRNA in H582 by clcclropho- 
rcsis in 2% agarosc gels. The puriticd I‘ragmcm was lignlcd with T4 
DNA ligase in buffer supplied by ~hc manufawrcr into a pUCl8 
vcclor (Takara Shuzoh) CUI with ~hc rrstriclion cndonuclcasc Sjrwl. 
A smell portion ws transfcclcd imocompctcnt host ccl!j (JM 109) and 
Ihc rcsullam ctoncs wcrc analyzed by hybridizalion Hith the 317-bp 
ampliticd fragmcni and by DNA scqucncc analysts using rhe didcoxy 
chain icrminalion method. 
2.6. De/cc/ion oJ’p27rcs rorrlp21 X profcitrs /g* lVc*.s/cr~~ hIor rrrw/)~.si.s 
Wcswrn blol analysis of p27rcx and p2lX was pcriormcd as dc- 
scribed previously [42]. Prolcins wcrc CxlrdClcd Tram cells. scparalcd 
by I88 SDS-polyacrylamidc gel clcclrophorcsis. and iransTerrcd LO H 
mcmbranc (Clcnr Blot mcmbranc-P; ATT0 Co.. Tokyo. Japan). 
Bloltcd prowins wcrc incubalcd with rabbi1 amibodg against C-w- 
minal pcplidc, which rcacls with both p27rcx and p2lX (a gili from 
I I. Shidz. Kj;GiG ‘L!fikCi%iy) L-v>,. fi IA. ~~~~~~~uliOCOEi~lCiics X!K! tic- rl’ll I-L.. :--.. 
kckd by binding with horseradish pcroxidasc-conjugsicd protein A 
end colored with iI Konik;l immunoslain kil (Konik;! CO.. Tokyo, 
Japan). 
3. RESULTS 
3. I. Fittchtlg of u noed ultenwtiwly spliced ttlRNA itt 
HTL V-l ittjktccl cell litws 
RNA from HTLV-1-inl’ected ccl1 lines was analyzed 
to cvaluatc the sensitivity and specificity of RT-PCR 
with primers PX3 and PX4 to detect tusltw mRNA as 
described previously [27]. Alter RT-PCR, WC confirmed 
the specific signal and sufficient sensitivity was observed 
to detect the amplifed band, 144-bp, derived from tusl 
a 
1 2 3 
/t 
C' 
8 
..A 
,142 
Fig. 2. Ethidium bromide slaininy and scqucncing or an amplified 
DNA I’ramcm dcrivcd ti-om ihc HTLV-I p2lX mRNA. A l44-bP(a) 
and a 3 I7-bp (b) amplified DNA by RT-PCR will1 primers PX3 and 
PX4. and PX I and PX2. rcspcclivcly. arc shown. RNA dcrivcd Tram 
Mob-4 (lane I), H582 (lane 2)and MT-2 (lane 3) wrc used as tcmplalc 
RNA. (c) Scqucncing auloradiogram orthc 317-bp rrapmcm prcpdrcd 
from H582 cells. The arrow indicalcs the posirion orthr spliccjunction 
of the uhcrnativcly spliced pX mRNA (p2lX mRNA shown in Fig. 
IA). Thcscqucncc shown hcrc is consislcnt with the scqucncc ofprobc 
PXG (Fig. I B). 
WY mRNA in HTLV-1 infected cell lines. MT-2 and 
H582 and not to detect any bands from an HTLV-1 
uninfected cell line, Molt-4 (Fig. 2a). On the other hand, 
when using primers PXI and PXZ, a 508-bp fragment 
was expected to be amplified from ttrslrcs mRNA by 
RT-PCR, but only a 317-bp fragment was observed to 
be amplified in MT-2 and H582 (Fig. 2b). The 317-bp 
band was not hybridized with the probe PX5 (data not 
shown) but was done with the oligo-probe PX6 (Fig. 4). 
From these findings, we postulated that the 317-bp frag- 
ment might be amplified from a putative alternatively 
spliced mRNA transcript which contains only the first 
and third exons of the turslres mRNA and codes for 
p2lX. 
To characterize this 3 17-bp-fragment, the l-ragmcnt 
was subcloncd into the pUCl8 vector and sequenced by 
the chain-termination method whh didcoxy nucleotidc 
(Fig. 2c) [401. The sequence data confirmed that the 
i-ragment did not contain the second cxon of !ZY!W_Y 
mRNA but just connected the first and third cxons of 
tuslres mRNA, and revealed that the amplified 317-bp 
fragment was derived from a novel alternatively spliced 
mRNA transcript (p2lX mRNA shown in Fig. I). 
To determine p2lX mRNA by an additional tcch- 
nique, Northern analysis was carried out using the 
oligo-probe PX6, which hybridized specifically to ~21 X 
mRNA but not to tuslrcx mRNA as mentioned above. 
In total RNA from H582 and MT-2, typical viral RNA 
(8.8, 4.2, 2.1 kb) was detected with the pX dsDNA 
fragment-probe, which can hybridize all viral RNA 
(Fig. 3a). However, ~21 X mRNA (I -5) kb) was detcctcd 
with the PX6 probe only in RNA from H582 (Fig. 3B). 
129 
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Fig. 3. Dclcrmim~~ion of lhc length ol’ p2lX mRNA by Norlhcrn 
analysis wilh ~hc specific oligo-probe. Toral RNA (I S ,w) from H582 
(hmc I). MT-! (hmc 2) and Mol1-4 (hmc 3) was I’ractionnlcd on ;I 
formaldshydc-gel. transl’errod to u nylon membrane liltcr nnd hgbrid- 
izcd with rlic HTLV-I pX dsDNA fragmcm-probe (429.bp: 7386-7814 
nl [6]) (A). lhc olipo-probe PX6 (B) and the/I-aclin dsDNA fr‘ra_micnl- 
probe (419.bp; 281-l l-11 m [A6]) (C). (A) RNA from H5S2 and MT-2 
wcreonalyzcd Tar HTLV-I Scnomic/&l8-pol(8.5 kb). cnv (4.2 kb). and 
las/rcs mRNA (?.I kb) RNA from H5S2 was analyzed for p2lX 
mRNA (1.9 kb). (C) RNA from H582, MT-2and Molt-4was annlyzcd 
for/I-acrin mRNA (I .9 kb). This expcrimcnt was perl‘ormcd to verify 
~!:a x equal mount of royal RNA was used for tlmc analyses. The 
mo:ccular standard bands (0.24-9.5 kb RNA Ladder; Bclhcsda Rc- 
search Laboralorics. RID. USA) ;Irc indicated a1 the left. 
It might be considered that the sensitivity of mRNA 
detection by Northern analysis is lower than that by the 
RT-PCR method and p2 IX mRNA expression in MT-2 
is low-level as shown in Fig. 2. The negative data in 
RNA from MT-2 is consistent with the RT-PCR data, 
showing that the expression levels of p21X mRNA in 
MT-2 were lower than that in H582 (Fig. 2), From the 
a b 
Fig. 4. RT-PCR and SouWrn analysis ol’an mnplilicd DNA fr;lgmcnl 
dcrivcd from p2lX mRNA in HTLV-I infcclcd cells. (a) The 144.bp 
amplified DNA iIs described in the lcgcnd of Fig. 2 is dulcrmincd by 
hybridization wilh the oligo-probe PX5 in RNA rrom MT-I (lane 3), 
MT-2 (lane 4), H582 (lanc 5). MT-4 (lane 6). and TL-Su (lane 7), bur 
not in dislillcd willcr (lane I) and Mob-4 (lane 2). (b) The 317.bp 
amplified DNA 3s dcscribcd in lhc lcgcnd of Fig. 2 is dclcrmincd by 
hybridizalion whh the oligo-probe PX6 in RNA from MT-2 (Iilnc 4). 
1-1582 (lane 5), MT-4 (I~IIC G), end TL-Su (lane 7), bul no1 in dislillcd 
Fig. 5. Wcstcrn blol analysis I’or p27rcx and p?lX in HTLV-I infc’cctcd 
cdl lines. TOWI cell cxWxts l’ro:a HTLV-I infcctcd cell lines, TL-Su 
(lime 2), MT-I (hoc 3). MT-2 (Iax 4), MT-4 (lane 5). snd H582 (Innc 
6),andan HTLV-I uninTcclcdccll lint, Mob-J(hmc I),wcrcscpnmbzd 
by SDS-polyacrylamidc gel clcctrophorcsis and lransfcrrcd LO ;I filler. 
p27rcx and p2lX wcrc rcvcalcd wilh rabbit ;mliscrun against both 
wacr (hlnc I), MoII-4 (lane 2), and MT-I (lane 3). prolcins. 
data of this Northern analysis, the presence of p2lX 
mRNA was also proven and the size (1.9 kb) of p2lX 
mRNA was consistent with the predicted one (1675 
bases + polyA tail (-300 bases) = -1.9 kb; Fig. I). 
Furthermore, we examined the expression of p2lX 
mRNA in other HTLV-I infected cell lines, MT-I, MT- 
4 ilnd TL-Su. as well as MT-& H582. and Molt-4 by 
RT-PCR and Southern hybridization. It is shown in 
Fig. 4a that the 144.bp fragment hybridized with the 
PX5 probe was amplified with primers PX3 and PX4 in 
RNA from MT-I. MT-2, MT-4. TL-Su and H582 but 
not from Molt-4. suggesting that taslres mRNA was 
specifically expressed in all HTLV-I infected cell lines 
used here. After RT-PCR with primers PXl and PXZ 
and hybridization with the PX6 probe, the 317.bp spe- 
cific signal amplified was observed in RNA from MT-2, 
M-r-4, TL-Su. and H582 but not from MT-l. Molt-4 
(Fig. 4b). Interestingly, a very high-level expression of 
p2lX mRNA was observed in H582, compared with 
thilt in MT-2, MT-4, and TL-Su. p2lX mRNA was not 
detected in MT-l, regardless of the presence of raslres 
mRNA. 
~21 X prolcil~ 
From rhe viral genomic structure, this alternatively 
spliced mRNA could code for p2 IX (Fig. I). To inves- 
tigate this possibility, Western blot nnalysis using anti- 
body against the C-terminus oligopeptide of p27rex/ 
p?.lX was carried out. In H582, a larger amount of 
p21X was detected than in MT-Z MT-4 and TL-Su 
(Fig. 5). However, no p2lX was detected in MT-I (Fig. 
5). confirming the published data as described previ- 
ously [8]. We already mentioned above that the expres- 
sion of p2 1X mRNA was strongly positive in H582 and 
negative in MT-l (Fig. 4). indicating that the amount 
ofp2IX in the HTLVII infected cell-lines 
1 2 3 4 5 6 
tended to be 
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A1. 3 ,b A2 ‘. 
1110967654321 M 1110987654321 
Fig. 6 Quantimtive dctcction of roslres mRNA and p2l X mRNA by RTIIS-PCR mc1hod. (A) Serial-diluted MT-2 IOLII RNA with Molt-4 total 
RNA wcrc amplified by RT-PCR (band d) or RT/TS-PCR (a and c), Tollowcd bycrhidium bromide-staining (A I and A2)ar Southern hybridization 
with PX5 and PX6 mix-probe (A3 and A4). In each amplification, 0.5 pug ol Mob-4 ccl1 toml RNA plus 5x10’ pg, 5x!!!’ pg. 5~10~ pg. 5x10’ pg. 
5x10” pg. 5x10-l pg. 5x10-’ pg_ 5xlO-z pg. SXIO-~ pg. 5x10-s pg. or 0 pg IO hlT-2 cell total RNA (lanes l-l I. rcspec1ivcly) wcrc used as template 
RNA. The scrics oT RT-PCR producls. l44-bp (d), dcrivcd Tram rcdrcs mRNA with primers, PX3 and PX4, arc show in Alb and A3b. The 
scrics or RT/TS-PCR products. 144.bp (4). derived from rmhw mRNA with primers. PX I and PX2, Toor ISI step amplikation and with primers, 
PX3 and PX4. for 2nd sicp runplifknion arc shown in Ala and A3a. The surics of RT-PCR produc1s. 272.bp (a-) and 8l-bp (G). derived from 
krslres mRNA and ~71 X mRNA, rcsp<ctivcly. with primers. PXIO and PX4. arc shown in A2b and A4b. The scrics of RTITS-PCR products. 
272.bp (+) and 81-bp (<), dcrivcd liom taslrcx mRNA and p2lX mRNA, rcspcctivcly. with primers. PXI and PX?. t-or 1st step amplification 
and with primers, PXIO and PX4. l-or 2nd step amplification arc shown in A2c and A4c. (B) Serial-diluted MT-I total RNA with MoII-4 total 
RNA as dcscribcd in (A) WIS amplified by RTITS-PCR with primers, PXI and PX2, for 1st step amplilica1ion and primers. PX3 and PX4 (e). 
or PXIO and PX4 (I), for 2nd s1cp amplifica1ion. (C) Serial-dilu1cd H582 total RNA with Molt-4 total RNA as described in (A) was amplified 
by RT/TS-PCR whh primers. PXI and PX 2. For 1st SICP amplifknion and primers. PX3 and PX4 (8). or PXIO ;tnd PX4 (h), for 2nd sicp 
ampliRca1ion. Two addirionirl amplified products. abou1200-bp (4) and abou1 l70-bp (a). arc shown in A2 and Ch. Thcrnolecular standard bands 
(Hwlll digested rpXl74 phagc DNA) arc indicated by the Icttcr. M. 
correlated with the level of p21X mRNA expression but 
not with that of W/W-~ mRNA expression, The 
evidence implies that p2lX might be translated mainly 
from p2 I X mRNA instead of fa.~/rcs mRNA in HTLV- 
1 infected cell lines. 
3.3. Highly settsirivc d quuttrirulive dekwiorl cf ~1x1 
rex tttRtVA md p21X tttRNA by RT/TS-PCR 
To evaluate the high sensitivity of the RT/TS-PCR 
method for detection of mRNA, we compared the sensi- 
tivity of RT/TS-PCR with that of RT-PCR using serial- 
diluted MT-2 ccl1 total RNA with Molt-4 cell total 
RNA as described in Fig. 6A. For detection of raslres 
mRNA, the specific detection for the RT-PCR products 
(144-bp) was observed only up to a dilution of lo-’ (Fig. 
6A I b), while the specific detection for the RT/TS-PCR 
products (144.bp) was observed up to a dilution of low7 
(Fig. 6Ala). For detection of p21X mRNA, the specific 
detection for the RT-PCR products (81-bp) was ob- 
served only up to a dilution of 10.’ (Fig. 6A2d), while 
the specific detection for the RT/TS-PCR products (81- 
bp) was observed up to a dilution of lo.* (Fig. 6A2c). 
These results demonstrated that RT/TS-PCR under 
these conditions is 1000 to 10 008 times more highly 
sensitive than RT-PCR. These RT/TS-PCR products 
were also qualitatively verified by the data of Southern 
hybridization experiments (Fig. 6A3 and 6A4). 
Morcovcr, we applied RT!TS-PCR to determine 
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amounts of roslres mRNA and p2lX mRNA in MT-l 
and H552. As shown in Fig. 6B. the RT/TS-PCR 
products (144-bp) derived from fcrslrcs mRNA in MT-l 
were detected up to a dilution of 10e6, while no RT/TS- 
PCR product derived from p2lX mRNA was detected 
up to a dilution of IO-‘. In other RT/TS-PCR experi- 
ments with undiluted total RNA of MT- 1. the fact that 
no band derived from p2 1 X mRNA was amplified (data 
not shown) strongly verified that MT-I cells express 
p2lX mRNA at an undetectable level or not at all. As 
shown in Fig. 6C. the RTiTS-PCR products (144-bp) 
derived from rctsl~s mRNA in HS82 were detected up 
to a dilution of IO-“. while the RT/TS-PCR products 
(El-bp) derived from p2lX mRNA were detected up to 
a dilution of IO-‘“. These results show that the amount 
of p2lX mRNA expression in H582 is over 10 times 
higher than that in MT-2 These quantitative data 
strongly suggest that p2iX mRNA is mainly re- 
sponsible for expressing pZlX in HTLV-1 infected cells 
but IN.Y/I’~.Y mRNA has very little or no responsibility 
for expressing p21X in infected cells. 
4. DISCUSSION 
‘To date. rf/rslres mRNA of HTLV-1 is well known to 
encode for p40rax. p27re.u and p2lX. and has been in- 
terpretcd !o exr~ess all of them. On the contrary, 
Kiyokawa et al: [8] suggested that there might be a 
furtherpossibility that p27rex and p2lX were independ- 
ent translation products from differently spliced 
mRNA. However, they found no evidence for alterna- 
tively spliced mRNA by blotting or nuclease Sl protec- 
tion assay [34]. Nagashima et al. [18] later demonstrated 
that ttrsl~s mRNA was a common transcript for 
p40tax, p27rex and p2lX. They cloned a cDNA clone 
Table I 
Positive corrclatioa bctwccn the lcvcl oTp2lX mRNA expression and 
the amount or pZlX protein cxprcsscd in HTLV-I infcctcd ccl1 lines 
Cei; lines 
MT-I 
hlT-2 
!kIT-4 
TL-Su 
H582 
MOII-4 
mRNA;’ Protein” 
lUS/WS p2lX p27rcx p2lX 
IV <IO” + 
IO’ IO” 
I Oh 10” y+ 
4.6 
+ 
IO’ IOh ff i 
IOh IO” + +i+ 
<IO” < I 0” - 
“Amounts of mRh’A arc quantitatively cstimatcd as dcscrib:d in the 
WXI. RNA was titrated in ten-fold dilutions t’or RT/TS-PCR and the 
reciprocal numbers or the endpoint dilutions which gave a positive 
wcrc indicated. 
“Eslimi~d the nmowtt of each protein cxprcsscd in cells scmiqunnti- 
tativcl~ by comparison of intensities of immunorcactcd bands on 
filters of Wcslcrn blot analysis (Fig. 5) with those or ihc most 
abundantly cxprcssing cells and cakgorizcd !hcm into four groups: 
(-) nobandwasvisible: (+) ~10% of the strongest; (++) >lO%orthc 
slrongust; (+++I the strongest. 
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derived from ~uslrvs mRNA. prepared pure mRNA of 
this cDNA clone using SP6 vector and the polymerase 
system, and translated it in vitro. They identified three 
pX proteins, p40tax, p27rex and p2lX, as products 
translated from the pure mRNA. Mutagenesis on AUG 
codons demonstrated that the first AUG codon in 
mRW? is for p27rex translation, the second for p40tax 
and the fourth for p2lX. These findings have clearly 
swept away the former possibility since then. 
In order to investigate the expression of pX mRNA 
in more detail, we developed a new technique, RT/TS- 
PCR. which is a combination of the two-step PCR [38] 
and RT-PCR. and is 1000-10 000 times more sensitive 
than the conventional RT-PCR so as to detect small 
amounts of mRNA without using radioisotopes. In 
addition to rcrslr~es mRNA. a novel mRNA was de- 
tected in most of the HTLV-i infected cell lines studied 
here by using RT-PCR and RT/TS-PCR. The DNA 
sequencing analysis of cDNA derived from the novel 
mRNA showed that !he novel mRNA contained only 
the first and third exons of the double spliced transcript 
(~a.~lrrs mRNA) but not the second exon, suggesting 
that this RNA was an alternatively spliced mRNA 
transcript, and the third exon only contained the p2lX 
coding frame, suggesting that this RNA could code for 
p2lX but not p27rex nor p40tax. The alternatively 
spliced mRNA in our HTLV-1 infected cells is the two- 
exon mRNA, which is analogous to the two-exon twf 
specific mRNA in HIV-I infected cells [29]. Moreover, 
by Northern analysis with an oligo-probe specific for 
this mRNA, we determined that the size of this mRNA 
is 1.9 kb. which is very close to that of rasl~s mRNA 
(2-l kb) [7]. Because of the similarity in size, therefore, 
the analysis of the relative expression levels of pX 
transcripts by Northern blots was not feasible. 
We then assumed that this new p2lX mRNA might 
be a specific transcript for p2lX. First, we isolated a 
specific cDNA clone derived from the p2lX mRNA, 
ligated the cDNA fragment at a sense orientation into 
an expression vector, pCD-SRcr [41], and examined the 
transient expression in COS cells (ATE CRL-1650) 
transfectcd with the construct plasmid DNA. In the 
transfected COS cells, p2lX but not p27rex was de- 
tected (data not shown). confirming that the cDNA 
from the p2lX mRNA contains the p21 coding frame 
and has the ability to express p2lX. Second, as sum- 
marized in Table I, we investigated the comparison be- 
tween the amounts of the rrrsl~s and p2lX mRNA and 
the amounts of p27rex and p2lX in HTLV-I infected 
cell lines. Although the rusl~~s mRNA and p27rcx were 
expressed in all HTLV-I infected cell lines tested, 11582, 
MT-l, MT-2, MT-4, TL-Su, but not in the HTLV-1 
uninfected cell line, Molt-4, the p2lX mRNA and p2lX 
were cxprcssed in most of HTLV-1 infected cell lines, 
such as 11582, MT-2, MT-4, TL-Su, except for MT-l 
and Molt-4. Interestingly, H582 cells express the largest 
amount of p2lX and of p2lX mRNA when compared 
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to other HTLV-I infected cell lines, MT-2, MT-4 and 
TL-Su. On the contrary. in MT-I cells, neither the pZlX 
mRNA nor p2lX was detected. Moreover, the level of 
this new p2lX mRNA expression was also found to be 
correlated with the amount of p2lX in the other HTLY- 
1 infected cell lines, MT-2, MT-4, TL-Su. These findings 
imply that p2 I X might be mainly translated from ~21 X 
mRNA instead of tcdrvs mRNA. 
However, according to another point of view, these 
results could indicate that a sequence alteration partic- 
ipated in p2lX translating in ~nsl~s mRNA. which 
commonly existed in HTLV-I infected cells, might be 
involved in the expression variation of p2 1 X. Therefore. 
we determined the sequence of rasl~es mRNA surroun- 
ding the p21X initiation codon by sequencing directly 
DNA fragments produced by RT-PCR. The sequence 
of’ cDi\lA from tnslr~~ mRNA in the three HTLV-1 
infected cell lines. MT-l. MT-2 and H582 (data not 
shown) was found to be completely identical to that of 
the HTLV-I ATK clone described previously, indicat- 
ing no presen.ce of any sequence alterations of tmkes 
mRNA surrounding the p2lX initiation codon in MT- 
I. MT-2 and H582. In consequence, the data sug_eest 
that tcrshes mRNA is little, if at all, responsible for 
translatin_e p2lX in HTLV-I infected cells. Thus. we 
can conclude that p2lX is translated from p21X 
mRNA. Moreover. in rcrshcs mRNA, the initiation 
codon of p2 1X is located downstream of the p27rex and 
p40tax initiation codons. and the translation initiation 
sequence surrounding the p2lX initiation codon does 
not conform closely to the Kozak consensus sequence 
[45]. Thus, p21X is likely to be translated more effi- 
ciently from p2lX mRNA than tnshes mRNA. but 
such detailed mechanisms are not clear yet and remain 
to be determined. From these data. we conclude that 
p21X is translated from p2lX mRNA in HTLV-I in- 
fected-cultured cell lines. Although it is not yet clear 
whether the presence of p21X is an absolute require- 
ment for the production of HTLV-I viral antigens. the 
results ii:dicate that p2lX may play a crucial role in the 
regulation of HTLV-I propagation. 
After RT/TS-PCR. two other faint bands (an about 
23O-bp band UCLWGFII 1. -._-.--.- ;he 272-b_ r and Sl-bp bands 
shown in Fig. 6A2c and an about 170-bp band between 
the 200.bp and 8 I-bp bands in Fig. 6Ch) was clearly 
found to be amplified additionally. These 200-bp and 
170-bp fragments were not hybridized with the 
oligo(mix-probe) (PX5 I- PX6) (Fig. 6A4 and data not 
shown), suggesting that these fragments are dcrivcd 
from different mRNA transcripts from tu.dm mRNA 
and p2lX mRNA. Our preliminary data (unpublished 
data) suggest that one of these transcripts is also an 
alternatively spliced mRNA, which uses the same splice- 
donor site but not the different splice-acceptor site of 
p21X mRNA, and contains the p2 IX coding irame. 
However, this mRNA seems to be very littlc, if not at 
all. responsible for encoding p2lX, because this mRNA 
expresses much smaller amounts than p21X mRNA in 
MT-2 and H582 cells. On the other hand, the other 
additional mRNA has not yet been ttharacterized, but 
the mRNA also shows low-level (c1/1000 or -=I/10 000) 
expression compared with p2lX mRNA expression in 
MT-2 or H582. Further detailed analyses are required 
for understanding the role of these mRNA in HTLV-I 
infection. 
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